Retatrutides Phase 2 monotherapy weight loss (~24.2% at 48 weeks) is numerically larger than cagrilintides (~10.8% at 26 weeks), but those come from different trials, durations, and doses, and cagrilintides strongest data are as the CagriSema combination
However, they can also affect digestion and how much you naturally feel like eating or drinking
The Journal of Allergy and Clinical Immunology: In Practice, 8 (1), 5267.
Eligibility Requirements for GLP-1RAs All patients who want to use GLP-1 medications must meet one of the following requirements: A BMI of 30 or above (obesity) A BMI of 27 or above (overweight) with a weight-related health condition such as high blood sugar levels, high blood pressure, or high blood fat levels
- After Reconstitution: Store reconstituted peptide at 28C and use within 30days